While Ashley McEvoy has only been at the helm of Insulet (Nasdaq:PODD) for five months, she’s already seeing the increasing role of AI in the company’s technology. Speaking during a “CEOs Unplugged” session covering the emergence of AI in medical technology at AdvaMed’s The MedTech Conference in San Diego alongside Stryker CEO Kevin Lobo and […]
Diabetes
Senseonics posts strong preliminary Q3 sales, reverse stock split
Senseonics (NYSE:SENS) today announced preliminary revenues for the third quarter and plans to conduct a reverse stock split. The Germantown, Maryland-based long-term implantable continuous glucose monitor maker expects approximately $8.1 million in revenue for the third quarter of 2025. That marks a 91% uptick from the third quarter of 2024. The company attributed its growth […]
Modular Medical appoints new head of international operations as insulin patch pump advances
Modular Medical (Nasdaq:MODD) announced today that it appointed David Bosshard as its new head of international operations. Bosshard joins the company as it looks to advance its insulin delivery technology. San Diego-based Modular Medical develops pump technology designed for “almost-pumpers.” It targets adults with a user-friendly, affordable design. Modular Medical’s current pump, the MODD1, won […]
GlucoSet wins FDA breakthrough nod for glucose biosensor tech
GlucoSet announced today on social media that it received FDA breakthrough device designation for its glucose monitoring technology. The company took to LinkedIn to share: “GlucoSet just received breakthrough device designation from the FDA! We’ve been pursuing this for a year and a half. Landing it puts us on the fastest possible path to U.S. […]
Court sides with Medtronic in insulin pump class action suit
A Minnesota judge has dismissed a class action lawsuit alleging securities fraud related to insulin pumps made by Medtronic (NYSE:MDT). Laura M. Provinzino, U.S. District Judge for the District of Minnesota, granted Medtronic’s motion to dismiss the suit initially brought forward by investors in 2022. Provinzino’s dismissal comes about a year-and-a-half after Katherine M. Menendez, […]
Tandem t:slim X2 pump cleared for use with Lilly’s Lyumjev ultra-rapid insulin
Tandem Diabetes Care (Nasdaq:TNDM) announced today that it received approval to deliver Lyumjev ultra-rapid acting insulin with its t:slim X2 pump. Eli Lilly offers the Lyumjev (insulin lispro-aabc injection) ultra-rapid acting insulin. Tandem can now provide its t:slim X2 pump with Control-IQ+ automated insulin delivery technology with the insulin in the U.S. This latest clearance […]
Sequel Med Tech, Arecor ink co-development agreement for ultra-rapid insulin with twiist
Arecor Therapeutics announced today that it signed a co-development with Sequel Med Tech to pair their diabetes offerings. Cambridge, UK-based Arecor develops AT278 (500U/mL) ultra-rapid-acting insulin. The companies struck a deal to pair the insulin with the Sequel twiist automated insulin delivery system. Additionally, the deal includes a financing agreement with Ligand Pharmaceuticals to bring […]
Biolinq wins FDA de novo nod for autonomous, needle-free CGM
Biolinq announced today that it received FDA de novo clearance for its lead product, the Biolinq Shine wearable biosensor. San Diego-based Biolinq can now scale its new generation of wearable sensors designed for comfort, simplicity and global reach. Its Shine sensor integrates glucose, activity and sleep information into a single device with autonomous operation. The […]
SiBionics reports strong CGM, ketone monitoring data
SiBionics announced the presentation of new data supporting its continuous glucose monitoring (CGM) and ketone monitoring (CKM) devices. The China-based company shared findings for its integrated CGM and CKM diabetes management solution as well. It showcased the technology at the 61st Annual Meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria. […]
Glooko acquires Monarch Medical and its diabetes management tech
Glooko announced today that it acquired Monarch Medical Technologies, maker of the EndoTool glucose management system. EndoTool, a leading software platform, offers capabilities for inpatient insulin dosing and glycemic management. Glooko said its acquisition expands its connected care capabilities into inpatient glycemic management. This complements the company’s foundation in outpatient diabetes. The FDA-cleared platform delivers […]
